Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.

Br J Cancer · 1999 · PMC2362953 · PMID 10576658

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

partially significantno p-value reported

In accordance, there was an increase in cytotoxic activity in PBL derived from the patients that was partially significant.

also in 417 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.